Cardiovascular-Kidney-Metabolic Livestream
- Nov. 12 – 13, 2026 (Thu–Fri)
- Online
- Credits pending
- Member$815
- Non-Member$1025
- New Physician$765
- Student$645
- Resident$645
- Other$815
Purchases may be subject to applicable sales tax.
Register by October 30, 2026 to save $100!
Join us for this dynamic, two-day online CME conference on what the American Heart Association identified as Cardiovascular-Kidney-Metabolic (CKM) Syndrome.
Cases of overlapping comorbidities are on the rise, with combinations of cardiovascular disease, type 2 diabetes and chronic kidney disease increasingly common. This livestream course will help you shift your therapeutic decision-making from managing individual diseases to comprehensive, whole-patient health plans.
Through Problem-Based Learning (PBL), you’ll turn content into real-world clinical decision-making. Sessions are divided into themed disease progression stages:
Join us for this dynamic, two-day online CME conference on what the American Heart Association identified as Cardiovascular-Kidney-Metabolic (CKM) Syndrome.
Cases of overlapping comorbidities are on the rise, with combinations of cardiovascular disease, type 2 diabetes and chronic kidney disease increasingly common. This livestream course will help you shift your therapeutic decision-making from managing individual diseases to comprehensive, whole-patient health plans.
Through Problem-Based Learning (PBL), you’ll turn content into real-world clinical decision-making. Sessions are divided into themed disease progression stages:
Work on prevention through exercise, weight management, nutrition, smoking cessation, vaccines and other lifestyle optimization strategies.
What you’ll learn
Practical risk assessment strategies you can apply immediately
Motivational strategies to strengthen patient engagement and adherence
Insight to address disparities in CKM detection and treatment to improve outcomes
Collaboration with an interdisciplinary team for coordinated CKM care
Schedule (all times CST)
8:00 – 8:30 a.m.
Welcome and Introduction of CKM – Justin Bailey, MD
Stages 0–1 – Focus on Prevention and Reducing the Development of Problematic Adiposity
8:30 – 9:15 a.m.
Assessing Risk – Prevent Development and Implementation
9:15 – 10:15 a.m.
Lifestyle Changes That Reduce Primary Risk, Prolong Life
10:15 – 10:30 a.m.
Break
10:30 – 11:30 a.m.
Primary Prevention with Pharmacology
11:30 a.m. – 12:30 p.m.
Lunch
Stage 2 – Focus on Reducing Metabolic Risk and CKD
12:30 – 12:45 p.m.
Stage 2 Introduction – Justin Bailey, MD
12:45 – 1:45 p.m.
Lipid Guideline Update
1:45 – 2:30 p.m.
Diabetes Guideline Update
2:30 – 2:45 p.m.
Break
2:45 – 3:30 p.m.
HTN – AHA vs. AFP Best Goal Number
3:30 – 4:30 p.m.
CKD and Anemia
4:30 p.m.
Recess
Stages 3 and 4 – Treatment of Subclinical and Clinical CVD
8:30 – 8:45 a.m.
Stages 3 and 4 Introduction – Justin Bailey, MD
8:45 – 9:30 a.m.
Coronary Artery Disease/Myocardial Infarction/Angina
9:30 – 10:15 a.m.
Cerebrovascular Disease
10:15 – 10:30 a.m.
Break
10:30 – 11:15 a.m.
Heart Failure
11:15 a.m. – 12:00 p.m.
Arrhythmias
12:00 – 1:00 p.m.
Lunch
1:00 – 1:45 p.m.
Assessing Social Determinants of Health in CKM
1:45 – 2:00 p.m.
When and How to Deprescribe: CKM Care of the Frail and Elderly
2:00 – 2:45 p.m.
Patient Motivation in Primary Prevention
2:45 – 3:00 p.m.
Break
3:00 – 3:30 p.m.
Case Studies/Problem-Based Learning – Stages 0–1
3:30 – 4:00 p.m.
Case Studies/Problem-Based Learning – Stage 2
4:00 – 4:30 p.m.
Case Studies/Problem-Based Learning – Stages 3–4
4:30 p.m.
Adjourn
Learning objectives
At the end of this course, you will be able to:
- Define Cardiovascular–Kidney–Metabolic (CKM) syndrome and apply CKM staging to risk-stratify patients in primary care.
- Apply current evidence-based guidelines to slow the progression of cardiovascular and kidney disease in patients with metabolic risk factors.
- Integrate pharmacologic and lifestyle-based strategies for the management of obesity as a chronic disease within the CKM framework.
- Differentiate heart failure phenotypes and chronic kidney disease stages to inform appropriate treatment and referral decisions.
- Implement team-based, multidisciplinary care strategies to improve outcomes for patients with cardiovascular-kidney metabolic multimorbidity.